Historical Valuation
Ultralife Corp (ULBI) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.43 is considered Undervalued compared with the five-year average of 24.23. The fair price of Ultralife Corp (ULBI) is between 8.76 to 14.40 according to relative valuation methord. Compared to the current price of 5.88 USD , Ultralife Corp is Undervalued By 32.9%.
Relative Value
Fair Zone
8.76-14.40
Current Price：5.88
32.9%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Ultralife Corp (ULBI) has a current Price-to-Book (P/B) ratio of 0.69. Compared to its 3-year average P/B ratio of 0.95 , the current P/B ratio is approximately -27.50% higher. Relative to its 5-year average P/B ratio of 0.90, the current P/B ratio is about -24.15% higher. Ultralife Corp (ULBI) has a Forward Free Cash Flow (FCF) yield of approximately 9.52%. Compared to its 3-year average FCF yield of 4.87%, the current FCF yield is approximately 95.37% lower. Relative to its 5-year average FCF yield of 3.91% , the current FCF yield is about 143.39% lower.
P/B
Median3y
0.95
Median5y
0.90
FCF Yield
Median3y
4.87
Median5y
3.91
Competitors Valuation Multiple
AI Analysis for ULBI
The average P/S ratio for ULBI competitors is 1.10, providing a benchmark for relative valuation. Ultralife Corp Corp (ULBI.O) exhibits a P/S ratio of 0.43, which is -60.77% above the industry average. Given its robust revenue growth of 21.51%, this premium appears sustainable.
Performance Decomposition
AI Analysis for ULBI
1Y
3Y
5Y
Market capitalization of ULBI increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of ULBI in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is ULBI currently overvalued or undervalued?
Ultralife Corp (ULBI) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.43 is considered Undervalued compared with the five-year average of 24.23. The fair price of Ultralife Corp (ULBI) is between 8.76 to 14.40 according to relative valuation methord. Compared to the current price of 5.88 USD , Ultralife Corp is Undervalued By 32.90% .
What is Ultralife Corp (ULBI) fair value?
ULBI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Ultralife Corp (ULBI) is between 8.76 to 14.40 according to relative valuation methord.
How does ULBI's valuation metrics compare to the industry average?
The average P/S ratio for ULBI's competitors is 1.10, providing a benchmark for relative valuation. Ultralife Corp Corp (ULBI) exhibits a P/S ratio of 0.43, which is -60.77% above the industry average. Given its robust revenue growth of 21.51%, this premium appears sustainable.
What is the current P/B ratio for Ultralife Corp (ULBI) as of Jan 10 2026?
As of Jan 10 2026, Ultralife Corp (ULBI) has a P/B ratio of 0.69. This indicates that the market values ULBI at 0.69 times its book value.
What is the current FCF Yield for Ultralife Corp (ULBI) as of Jan 10 2026?
As of Jan 10 2026, Ultralife Corp (ULBI) has a FCF Yield of 9.52%. This means that for every dollar of Ultralife Corp’s market capitalization, the company generates 9.52 cents in free cash flow.
What is the current Forward P/E ratio for Ultralife Corp (ULBI) as of Jan 10 2026?
As of Jan 10 2026, Ultralife Corp (ULBI) has a Forward P/E ratio of 6.57. This means the market is willing to pay $6.57 for every dollar of Ultralife Corp’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Ultralife Corp (ULBI) as of Jan 10 2026?
As of Jan 10 2026, Ultralife Corp (ULBI) has a Forward P/S ratio of 0.43. This means the market is valuing ULBI at $0.43 for every dollar of expected revenue over the next 12 months.